Dr Reddy's Gets 7 USFDA Observations for Bachupally Biologics Plant Written By Parthika Patel27 Jun 2026 8:25 PM ISTNew Delhi: Dr. Reddy's Laboratories Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed...
Dr Reddy's Labs Gets SEC Nod to Manufacture, Market Oral Semaglutide Tablets Written By Susmita Roy25 March 2026 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to Dr....
USFDA Closes Inspection of Dr Reddy's Srikakulam Facility with VAI Classification Written By Parthika Patel7 March 2026 8:38 PM ISTNew Delhi: Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its...
NPPA Committee Caps Price of Akums' Cetirizine Eye Drops at Rs 14.42 per ml Written By Susmita Roy3 Jan 2026 4:49 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Cetirizine Hydrochloride IP eq. to Cetirizine 0.24 % w/v...
Dr Reddy's Denosumab Biosimilar AVT03 Faces USFDA Setback After Plant Inspection Written By Farhat Nasim1 Jan 2026 5:54 PM ISTNew Delhi: Drug major Dr Reddy's Laboratories Limited's wholly owned subsidiary, Dr. Reddy's Laboratories SA, Switzerland, has received a Complete...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Written By Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Cybercriminals Trick Dr Reddy's Finance Team, Divert Rs 2.16 Crore Payment Written By Parthika Patel10 Nov 2025 7:19 PM ISTBengaluru: In a major cybercrime incident, Dr Reddy's Laboratories Ltd has been duped of Rs 2.16 crore after hackers impersonated a senior executive...
Dr. Reddy's Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment Written By Susmita Roy6 Nov 2025 3:17 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Dr. Reddy's...
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Written By Susmita Roy20 Oct 2025 5:35 PM ISTNew Delhi: In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee (SEC) functional...
Game-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year Farhat Nasim25 Sept 2025 3:51 PM ISTBengaluru: Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly...
Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML Susmita Roy17 Aug 2025 4:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...
Dr Reddy's Gets CDSCO Panel Approval To Begin Phase III Trial of Tapinarof Cream Parthika Patel7 Aug 2025 11:41 PM ISTNew Delhi: Dr. Reddy's Laboratories Limited has received approval from the Subject Expert Committee (SEC) under CDSCO to conduct a Phase III clinical...
